BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38764552)

  • 1. Clozapine-Related Functional Bowel Obstruction: A Rare Adverse Effect Unmasking Quetiapine and Benztropine Interaction Raising Need for Bowel Surveillance.
    Tiwari A; Kambhatla S; George N; Anumolu P; Malik N; Kambhatla S
    ACG Case Rep J; 2024 May; 11(5):e01351. PubMed ID: 38764552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clozapine-Induced Gastrointestinal Hypomotility: A 22-Year Bi-National Pharmacovigilance Study of Serious or Fatal 'Slow Gut' Reactions, and Comparison with International Drug Safety Advice.
    Every-Palmer S; Ellis PM
    CNS Drugs; 2017 Aug; 31(8):699-709. PubMed ID: 28623627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases.
    Palmer SE; McLean RM; Ellis PM; Harrison-Woolrych M
    J Clin Psychiatry; 2008 May; 69(5):759-68. PubMed ID: 18452342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focussing on the fundaments - assessing and treating Clozapine Induced Gastrointestinal Hypomotility.
    Blackman G; Kapila A; Grosskopf CM; Dratcu L
    Int J Psychiatry Clin Pract; 2020 Mar; 24(1):18-19. PubMed ID: 31910056
    [No Abstract]   [Full Text] [Related]  

  • 5. Clozapine-induced gastrointestinal hypomotility: presenting features and outcomes, UK pharmacovigilance reports, 1992-2017.
    Handley SA; Every-Palmer S; Ismail A; Flanagan RJ
    Br J Psychiatry; 2022 Feb; ():1-9. PubMed ID: 35164895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine induced gastrointestinal hypomotility: A potentially life threatening adverse event. A review of the literature.
    West S; Rowbotham D; Xiong G; Kenedi C
    Gen Hosp Psychiatry; 2017 May; 46():32-37. PubMed ID: 28622812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Constipation screening in people taking clozapine: A diagnostic accuracy study.
    Every-Palmer S; Inns SJ; Ellis PM
    Schizophr Res; 2020 Jun; 220():179-186. PubMed ID: 32245597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Underexposed, potential lethal gastrointestinal adverse events associated with clozapine use].
    van Haaren PCF; Zwanenburg PR; Hendriks ER; Gerritse FL
    Tijdschr Psychiatr; 2022; 64(6):377-381. PubMed ID: 35748149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reporting of clozapine-induced gastrointestinal hypomotility and factors associated with fatal outcomes in Canada: A pharmacovigilance database study.
    Liu CL; Maruf AA; Bousman CA
    Psychiatry Res; 2020 Aug; 290():113048. PubMed ID: 32474068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clozapine Triggering Cecal Volvulus in a Patient With Malrotation and Schizophrenia: Side Effect That Needs Emphasis.
    Aneja J; Varshney V; Ks S; Singhai K; Yadav T
    Cureus; 2020 May; 12(5):e7971. PubMed ID: 32523828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Porirua Protocol in the Treatment of Clozapine-Induced Gastrointestinal Hypomotility and Constipation: A Pre- and Post-Treatment Study.
    Every-Palmer S; Ellis PM; Nowitz M; Stanley J; Grant E; Huthwaite M; Dunn H
    CNS Drugs; 2017 Jan; 31(1):75-85. PubMed ID: 27826741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clozapine in the treatment of refractory schizophrenia: a practical guide for healthcare professionals.
    Flanagan RJ; Lally J; Gee S; Lyon R; Every-Palmer S
    Br Med Bull; 2020 Oct; 135(1):73-89. PubMed ID: 32885238
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy.
    Cohen D; Bogers JP; van Dijk D; Bakker B; Schulte PF
    J Clin Psychiatry; 2012 Oct; 73(10):1307-12. PubMed ID: 23140648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine-Associated Aspiration During Electroconvulsive Therapy.
    Estime SR; Berg SM; Henry ME
    J ECT; 2019 Jun; 35(2):133-134. PubMed ID: 30308569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does switching to another antipsychotic in patients with clozapine-associated granulocytopenia solve the problem? Case series of 18 patients.
    Coşar B; Taner ME; Eser HY; Altınöz AE; Tarhan R
    J Clin Psychopharmacol; 2011 Apr; 31(2):169-73. PubMed ID: 21346615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clozapine versus other atypical antipsychotics for schizophrenia.
    Asenjo Lobos C; Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Leucht S
    Cochrane Database Syst Rev; 2010 Nov; (11):CD006633. PubMed ID: 21069690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Admission Types in Medically Hospitalized Patients Prescribed Clozapine.
    Leung JG; Hasassri ME; Barreto JN; Nelson S; Morgan RJ
    Psychosomatics; 2017; 58(2):164-172. PubMed ID: 28153339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing clozapine-related morbidity and mortality: 5 years of experience with the Clozaril National Registry.
    Honigfeld G; Arellano F; Sethi J; Bianchini A; Schein J
    J Clin Psychiatry; 1998; 59 Suppl 3():3-7. PubMed ID: 9541331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.
    Barber S; Olotu U; Corsi M; Cipriani A
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD006324. PubMed ID: 28333365
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.